未登录

A

Alin Girnita

pennsylvania commonwealth system of higher education (pcshe)

H指数:32

被引数:2,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-12-013

PRE

Kongtim, Piyanuch; Vittayawacharin, Pongthep; Zou, Jun; Srour, Samer; Shaffer, Brian; Shapiro, Roman M.; Varma, Ankur; Mcguirk, Joseph; Dholaria, Bhagirathbhai R.; Mccurdy, Shannon R.; Dezern, Amy E.; Bejanyan, Nelli; Bashey, Asad; Furst, Sabine; Castagna, Luca; Mariotti, Jacopo; Ruggeri, Annalisa; Bailen, Rebeca; Teshima, Takanori; Xiao-Jun, Huang; Bonfim, Carmen; Aung, Fleur; Cao, Kai; Carpenter, Paul A.; Hamadani, Mehdi; Askar, Medhat; Fernandez-Vina, Marcelo; Girnita, Alin; Ciurea, Stefan O.

Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma (vol 36, pg 3274, 2017)

IF7.3

2024-09-090

PRE

Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates

TRANSPLANTATION

IF5

2022-09-024

OA

Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF9.4

2021-12-0115

OA

Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2020-02-0122

OAAI

A prospective, iterative, adaptive trial of carfilzomib-based desensitization

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2020-02-0142

OAAI

Reducing Donor-specific Antibody During Acute Rejection Diminishes Long-term Renal Allograft Loss: Comparison of Early and Late Rejection

TRANSPLANTATION

IF5

2020-01-298

PREAI

ALLOANTIBODY TESTING IN TRANSPLANTATION: TO BIND OR NOT TO BIND COMPLEMENT?

HUMAN IMMUNOLOGY

IF2.2

2019-09-010

PREAI

THE NOVEL RECOMBINANT HLA-A*11:271 STORY: SEROLOGY TO THE RESCUE OF THE MISNOMENCLATURE

HUMAN IMMUNOLOGY

IF2.2

2018-10-010

PREAI

ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODIES ARE ASSOCIATED WITH POSITIVE FLOW CROSSMATCHES IN HEART TRANSPLANT CANDIDATES

HUMAN IMMUNOLOGY

IF2.2

2018-10-010

PREAI

Donor Specific Antibody Shows Different IgG Subtype in Early versus Late Antibody Mediated Renal Allograft Rejection

TRANSPLANTATION

IF5

2018-07-010

PREAI

COMPARISON OF ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODY RESPONSE IN DESENSITIZATION VERSUS NATURAL HISTORY OF TRANSPLANT CANDIDATES

HUMAN IMMUNOLOGY

IF2.2

2017-09-010

PREAI

ANALYSIS OF MULTI-YEAR TRALI TESTING USING LUMINEX SOLID PHASE PRODUCT

HUMAN IMMUNOLOGY

IF2.2

2017-09-010

PREAI

CHALLENGES IDENTIFYING ANTIBODIES USING SOLID PHASE METHODS WHEN CONTROLS FAIL

HUMAN IMMUNOLOGY

IF2.2

2016-09-010

PREAI

HIGH PREVALENCE OF ANTI-ANGIOTENSIN II TYPE 1 RECEPTOR ANTIBODY IN HLA-SENSITIZED TRANSPLANT CANDIDATES

HUMAN IMMUNOLOGY

IF2.2

2016-09-010

PREAI

DONOR-SPECIFIC ANTI-HUMAN LEUKOCYTE ANTIBODIES OF IMMUNOGLOBULIN G3 SUBTYPE ARE ASSOCIATED WITH HIGH-GRADE REJECTION IN PEDIATRIC HEART TRANSPLANTATION

HUMAN IMMUNOLOGY

IF2.2

2016-09-010

PREAI

Correlation between Solid Phase Assays and Positive CDC Crossmatches in a Surrogate Transplant Model

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2016-04-010

OAAI

Donor-Specific Anti-HLA Antibodies of Immunoglobulin G3 Subclass Correlate with Cellular Rejection after Cardiac Transplantation

JOURNAL OF HEART AND LUNG TRANSPLANTATION

IF6

2016-04-010

OAAI

EPITOPE CLUSTER ANALYSIS FOR DONOR-SPECIFIC ANTIBODY IDENTIFICATION IN ELUATES FROM FINE-NEEDLE ALLOGRAFT BIOPSY.

HUMAN IMMUNOLOGY

IF2.2

2015-10-010

PREAI

CROSSMATCH CONUNDRUMS: CAN WE GUESS WHICH GRAFT WILL NOT BE REJECTED?.

HUMAN IMMUNOLOGY

IF2.2

2015-10-010

PREAI